Mandao, Sherlyn B.

HRN: 29-23-67  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/01/2026
07/08/2026
IV
815mg
Q6hours
PCAP-B
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: